Clinical judgment versus biomarker prostate cancer gene 3: Which is best when determining the need for repeat prostate biopsy?

Bertrand Tombal, Gerald L. Andriole, Alexandre De La Taille, Paolo Gontero, Alexander Haese, Mesut Remzi, Mark Speakman, Louis Smets, Herman Stoevelaar

Research output: Contribution to journalArticle

24 Scopus citations

Fingerprint Dive into the research topics of 'Clinical judgment versus biomarker prostate cancer gene 3: Which is best when determining the need for repeat prostate biopsy?'. Together they form a unique fingerprint.

Medicine & Life Sciences